Category: Specific Treatments

Specific Treatments

5-ASA

Mesalamine

Steroids

Budesonide

Infliximab

Remicade

Adalimumab

Humira

Thiopurines

Imuran, 6-MP

Vedolizumab

Entyvio

Ustekinumab

Stelara

Tofacitinib

Xeljanz

Email Newsletter

Recent News

FDA accepts investigational NDA for ulcerative colitis therapy
January 21, 2020
Microscopic colitis may increase risk for incident IBD
January 20, 2020
JAK inhibitors may increase risk for herpes zoster in patients with IBD
January 15, 2020
Recurrent low-grade dysplasia increases CRC risk in patients with IBD
January 13, 2020
Highlights from AIBD 2019
January 11, 2020
IBD associated with gestational diabetes, other poor pregnancy outcomes
January 10, 2020
One-third of pregnant women with IBD experience postpartum flares
January 10, 2020
Low-FODMAP diet helps manage gut symptoms in quiescent IBD
January 10, 2020
7 Recent reports in IBD
December 31, 2019
Switch to Entyvio after calcineurin inhibitor induction safe, effective for ulcerative colitis
December 27, 2019